The relationship of urocortin-2 with insulin resistance patients having PCOS.

about

The relationship of urocortin-2 with insulin resistance patients having PCOS.

Item

http://www.wikidata.org/entity/Q51276343

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@en

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@nl

type

Item

label

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@en

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@nl

prefLabel

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@en

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@nl

P1476

The relationship of urocortin-2 with insulin resistance patients having PCOS.

@en

P2093

Erman Sever

http://www.w3.org/2001/XMLSchema#string

Mehmet Calan

http://www.w3.org/2001/XMLSchema#string

Muzaffer Temur

http://www.w3.org/2001/XMLSchema#string

Pelin Özün Özbay

http://www.w3.org/2001/XMLSchema#string

Saliha Aksun

http://www.w3.org/2001/XMLSchema#string

Serkan Kumbasar

http://www.w3.org/2001/XMLSchema#string

Özgür Yılmaz

http://www.w3.org/2001/XMLSchema#string

P2860

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis

Novel action of pituitary urocortin 2 in the regulation of expression and secretion of gonadotropins

Involvement of mTOR in Type 2 CRF Receptor Inhibition of Insulin Signaling in Muscle Cells.

Insulin resistance in polycystic ovary syndrome: progress and paradoxes.

Clinical assessment of body hair growth in women.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

The prevalence and features of the polycystic ovary syndrome in an unselected population.

Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?

P304

124-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09513590.2016.1240772

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27841039

http://www.w3.org/2001/XMLSchema#string